Senior Oncology Territory Manager Rare Disease
Daiichi Sankyo, Inc. headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group. Global clinical development and regulatory activities are headquartered at Daiichi Sankyo Pharma Development in Edison, New Jersey. \r\n\r\nOur team of more than 1,400 U.S. employees is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, thrombotic disorders, stroke risk reduction, dyslipidemia, diabetes, acute coronary syndrome, opioid-induced constipation and metastatic melanoma. \r\n\r\nWith over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.\r\n\r\nIMPORTANT NOTE: We are very pleased to announce the location of Daiichi Sankyo, Inc.’s new US headquarters where our Parsippany- and Edison-based teams will be co-located in a combined site in early to mid-2017. Our new headquarters will be in Basking Ridge, New Jersey at 211 Mt. Airy Road.
Carmen Y. Reiss 91 Webster Dr. · Wayne, New Jersey 07470 201-240-8713 · carmenespinal319@yahoo.com PROFESSIONAL EXPERIENCE: Daiichi Sankyo, Parsippany NJ Oncology Territory Manager . Jersey city NJ 2017- Present • Provide product and disease state related education to health care professionals in the medical community within my assigned territory. Focused on the assigned targeted segments (i.e.: Nephrology, GI, Hospital, Hematology/Oncology, OB/GYN and Pain Management). • Develop strong relationships with infusion center nurses and hematologists. Clinically present all reasons why they should choose Injectafer. • Work with specialty pharmacies to ensure solo infusion practice can get injectafer (Brown or White bagging or Buy and Bill) • Regional Sales Trainer for the North-East Region. • Ranked #2 in the nation QTD. • 179% to goal with Injectafer. • Currently ranked in the top 5% for both lead products. Senior Specialty Sales Representative 2014-2017 • Developed influential relationships with office based cardiology, interventional Cardiologist, high decile antiplatelet and anticoagulants writing physicians. • Continually enhanced product and disease state knowledge through assigned training and communication with co-promotion partners. • Developed a hospital customer base including applicable physician specialties, nurses, hospital department residents, fellows, pharmacist, and P&T to gain products formulary win. • Partnered with hospital Cardiovascular treatment committees to include DSI products on disease state protocols facilitate transition to outpatient environment via discharge protocols orders. • Products sold: Savaysa, Effient • Ranked #1 for the entire year of 2016 for Savaysa. • Highest Nation commission payout first year as a specialty representative. • Consistently ranked in the top 10%.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Carmen Reiss at Daiichi Sankyo then you’ve come to the right place.
Wondering if it's carmen@dsi.com, carmen.reiss@dsi.com, reiss@dsi.com, or creiss@dsi.com? We have the answers for you.